Regionshospitalet Viborg

Viborg 8800

1 studies enrolling now · 9 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Coronary Heart Disease (CHD), Critical Limb Ischemia, Hypoparathyroidism, Myocardial Infarction, Myocardial Infarction Old, Myocardial Infarction, Acute, Severe Hypertriglyceridemia

Studies at this site

• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial — Recruiting now
• A Registry for Participants With Chronic Hypoparathyroidism — Completed
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study — Completed
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction — Completed
• Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia — Stopped early